More than 1 billion people worldwide are likely to have elevated Lp(a) but levels vary with ethnicity and gender. Professor Pia Kamstrup, Copenhagen University Hospital, Denmark, discusses the evidence and its implications for cardiovascular risk in different populations.
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
(Founding Partner)